Literature DB >> 9392499

Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation.

H Sugimoto1, K Shikata, K Hirata, K Akiyama, M Matsuda, M Kushiro, Y Shikata, N Miyatake, M Miyasaka, H Makino.   

Abstract

Mononuclear cells, including monocytes/macrophages and T-cells, are considered to be involved in the progression of diabetic nephropathy, although the mechanism of their recruitment into diabetic glomeruli is unclear. The intercellular adhesion molecule-1 (ICAM-1) promotes the infiltration of leukocytes into atherosclerotic lesions as well as inflammatory tissues. In the present study, we investigated the expression of ICAM-1 in the glomeruli of streptozotocin-induced diabetic rats. The expression of ICAM-1 was increased significantly during the early stage of diabetes. The number of mononuclear cells, primarily monocytes/macrophages and lymphocytes, was significantly increased in diabetic glomeruli. Mononuclear cell infiltration into diabetic glomeruli was prevented by anti-ICAM-1 monoclonal antibody. Insulin treatment decreased ICAM-1 expression and mononuclear cell infiltration. The ICAM-1 expression on cultured human umbilical vein endothelial cells was not induced under high glucose culture conditions. Glomerular hyperfiltration is a characteristic change in the early stage of diabetic nephropathy. Treatment with aldose reductase inhibitor, which prevented glomerular hyperfiltration without changes in blood glucose levels, decreased ICAM-1 expression and mononuclear cell infiltration. Moreover, we examined the ICAM-1 expression in the glomeruli of the 5/6 nephrectomized rat, which is a model for glomerular hyperfiltration without hyperglycemia. The ICAM-1 expression and infiltration of mononuclear cells was significantly increased in the glomeruli of 5/6 nephrectomized rats. We conclude that ICAM-1 is upregulated and promotes the recruitment of mononuclear cells in diabetic glomeruli. Moreover, glomerular hyperfiltration that occurs in the early stage of diabetic glomeruli may be one of the potential mechanisms of ICAM-1 upregulation in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9392499     DOI: 10.2337/diab.46.12.2075

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  56 in total

1.  Renoprotective effects of clarithromycin via reduction of urinary MCP-1 levels in type 2 diabetic patients.

Authors:  Atsuhito Tone; Kenichi Shikata; Koichi Nakagawa; Masaaki Hashimoto; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2010-11-03       Impact factor: 2.801

2.  Intercellular adhesion molecule-1 plays a critical role in glomerulosclerosis after subtotal nephrectomy.

Authors:  Yuichi Kido; Daisuke Ogawa; Kenichi Shikata; Motofumi Sasaki; Ryo Nagase; Shinichi Okada; Hitomi Usui Kataoka; Jun Wada; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2010-12-23       Impact factor: 2.801

Review 3.  The pathologic continuum of diabetic vascular disease.

Authors:  Gabriela Orasanu; Jorge Plutzky
Journal:  J Am Coll Cardiol       Date:  2009-02-03       Impact factor: 24.094

Review 4.  New molecular insights in diabetic nephropathy.

Authors:  Ionel Alexandru Checheriţă; Gina Manda; Mihai Eugen Hinescu; Ileana Peride; Andrei Niculae; Ştefana Bîlha; Angelica Grămăticu; Luminiţa Voroneanu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

Review 5.  Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Authors:  Raimund Pichler; Maryam Afkarian; Brad P Dieter; Katherine R Tuttle
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-24

Review 6.  Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

Authors:  Donald E Kohan; David M Pollock
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

Review 7.  Therapeutic approaches to diabetic nephropathy--beyond the RAS.

Authors:  Beatriz Fernandez-Fernandez; Alberto Ortiz; Carmen Gomez-Guerrero; Jesus Egido
Journal:  Nat Rev Nephrol       Date:  2014-05-06       Impact factor: 28.314

8.  Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis.

Authors:  D Ogawa; K Shikata; M Matsuda; S Okada; J Wada; S Yamaguchi; Y Suzuki; M Miyasaka; S Tojo; H Makino
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

9.  Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy.

Authors:  Ting-Chi Lu; Zhao-Hui Wang; Xiaobei Feng; Peter Y Chuang; Wei Fang; Yuhong Shen; David E Levy; Huabao Xiong; Nan Chen; John Cijiang He
Journal:  Kidney Int       Date:  2009-04-08       Impact factor: 10.612

10.  Decreased ADP-ribosyl cyclase activity in peripheral blood mononuclear cells from diabetic patients with nephropathy.

Authors:  Michio Ohtsuji; Kunimasa Yagi; Miyuki Shintaku-Kubota; Yukiko Kojima-Koba; Naoko Ito; Masako Sugihara; Naoto Yamaaki; Daisuke Chujo; Atsushi Nohara; Yoshiyu Takeda; Junji Kobayashi; Masakazu Yamagishi; Haruhiro Higashida
Journal:  Exp Diabetes Res       Date:  2009-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.